Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21670463.
- Also identified by DOI 10.1200/JCO.2010.32.6223.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Members of the micropthalmia (MiT) family of transcription factors (MITF, TFE3, TFEB, and TFEC) are physiologic regulators of cell growth, differentiation, and survival in several tissue types. Because their dysregulation can lead to melanoma, renal cell carcinoma, and some sarcomas, understanding why these genes are co-opted in carcinogenesis may be of general utility. Here we describe the structure of the MiT family of proteins, the ways in which they are aberrantly activated, and the molecular mechanisms by which they promote oncogenesis. We discuss how meaningful understanding of these mechanisms can be used to elucidate the oncogenic process. Because the expression of these proteins is essential for initiating and maintaining the oncogenic state in some cancer types, we propose ways that they can be exploited to prevent, diagnose, and rationally treat these malignancies.
Medical subject headings
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
- Microphthalmia-Associated Transcription Factor
- Neoplasms